Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma

BACKGROUND: Despite the recent improvements in multimodal therapies for oesophageal squamous cell carcinoma (ESCC), the prognosis remains poor. The identification of suitable biomarkers for predicting the prognosis and chemo-sensitivity is required to develop targeted treatments and improve treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Hara, Hisashi, Takahashi, Tsuyoshi, Serada, Satoshi, Fujimoto, Minoru, Ohkawara, Tomoharu, Nakatsuka, Rie, Harada, Emi, Nishigaki, Takahiko, Takahashi, Yusuke, Nojima, Satoshi, Miyazaki, Yasuhiro, Makino, Tomoki, Kurokawa, Yukinori, Yamasaki, Makoto, Miyata, Hiroshi, Nakajima, Kiyokazu, Takiguchi, Shuji, Morii, Eiichi, Mori, Masaki, Doki, Yuichiro, Naka, Tetsuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931380/
https://www.ncbi.nlm.nih.gov/pubmed/27310703
http://dx.doi.org/10.1038/bjc.2016.183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931380/
https://www.ncbi.nlm.nih.gov/pubmed/27310703
http://dx.doi.org/10.1038/bjc.2016.183

Ejemplares similares